English | Español

Technology/Innovation
+ Technology/Innovation
Carol Ostrow | Dec 16, 2017

Multiple myeloma study results encouraging, GSK says
+ Technology/Innovation
Carol Ostrow | Dec 16, 2017

Zika vaccine deemed sustainable, immunogenic
+ Community
Carol Ostrow | Dec 16, 2017

American Heart Association taps Kinard as general counsel
+ Community
Carol Ostrow | Dec 16, 2017

Vanderbilt supports initiative aiming to reduce number of primary cesarean births
+ Technology/Innovation
Carol Ostrow | Dec 16, 2017

CSL partners with Vitaeris for organ transplant therapy
+ Regulatory
Carol Ostrow | Dec 15, 2017

GSK receives FDA approval for expanded use of Nucala
+ Technology/Innovation
Carol Ostrow | Dec 15, 2017

GSK says Shingrix promising for preventing shingles in stem cell transplant patients
+ Technology/Innovation
Marian Johns | Dec 15, 2017

Bioengineered ovaries may be safer than traditional hormone replacement, Wake Forest researchers find

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'